ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals
Arrowhead Pharmaceuticals Licenses Clinical MASH Program Targeting PNPLA3 to Madrigal Pharmaceuticals
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
U.S. Bank Freight Payment Index: Shipper Spending Surges Amid Modest Freight Volumes
Townsquare Announces Digital Advertising Partnership With Broadway Media
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
CrowdStrike Falcon OverWatch for Defender Extends Managed Threat Hunting to Microsoft Endpoint Customers
Bay Area Luxury Home Prices Have Jumped 13% Since Launch of ChatGPT
Lineage Cell Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update on May 12, 2026
Howmet Aerospace to Host Virtual Webcast of Annual Meeting of Shareholders